Infectious diseases and bacterial resistance in animal husbandry cause significant economic loss. Reducing reliance on synthetic antibiotics while maintaining herd health prevents systemic production failures.

Injectable lipid and vitamin formulations are susceptible to chemical breakdown when subjected to high-heat sterilization processes. Preventing this degradation ensures product safety and maintains pharmaceutical potency.

Inefficient metabolic pathways and poor expression stability limit the production of therapeutic proteins and vaccines. Overcoming these bottlenecks increases manufacturing throughput and bioactivity.